Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

VCXB

10X Capital Venture Acquisition Corp III

May 02 • 04:00PM ET

10.87

Dollar change 0.00
Percentage change 0.00	%

Financial • Shell Companies • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.13	Insider Own	6.68%	Shs Outstand	13.19M	Perf Week	0.09%
Market Cap	143.38M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	12.31M	Perf Month	0.83%
Income	-1.25M	PEG	-	EPS next Q	-	Inst Own	15.44%	Short Float	0.01%	Perf Quarter	2.07%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	7.95%	Short Ratio	0.04	Perf Half Y	5.74%
Book/sh	1.59	P/B	6.83	EPS next Y	-	ROA	-0.71%	Short Interest	0.00M	Perf Year	8.59%
Cash/sh	0.05	P/C	220.58	EPS next 5Y	-	ROE	-0.79%	52W Range	10.35 - 11.00	Perf YTD	1.21%
Dividend Est.	-	P/FCF	275.72	EPS past 5Y	-	ROI	-5.18%	52W High	-1.18%	Beta	0.07
Dividend TTM	-	Quick Ratio	0.15	Sales past 5Y	-	Gross Margin	-	52W Low	5.02%	ATR (14)	0.04
Dividend Ex-Date	-	Current Ratio	0.15	EPS Y/Y TTM	-841.04%	Oper. Margin	0.00%	RSI (14)	57.80	Volatility	0.00% 0.21%
Employees	-	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-657.78%	Payout	-	Rel Volume	0.00	Prev Close	10.87
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	32.24K	Price	10.87
SMA20	0.18%	SMA50	0.95%	SMA200	3.92%	Trades		Volume	1	Change	0.00%

Apr-23-24 04:42PM	10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing (GlobeNewswire)
Jan-31-24 05:16PM	10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance (GlobeNewswire)
Jan-08-24 06:00AM	10X Capital Venture Acquisition Corp. III Announces Expected Change in Management (GlobeNewswire)
Nov-28-23 04:10PM	10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing (GlobeNewswire)
Oct-04-23 06:07PM	10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American (GlobeNewswire)
09:07PM	Loading…
Aug-09-23 09:07PM	Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III (GlobeNewswire)
07:02PM	Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III (GlobeNewswire)

10x Capital Venture Acquisition Corp. III is a blank check company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 10, 2021 and is headquartered in New York, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VCXB

10X Capital Venture Acquisition Corp III

Upgrade your FINVIZ experience